Keywords: IVIM, IVIM, Hypoxia,Androgen Deprivation Therapy,Prostate Cancer,Treatment Response
Motivation: Our previous study established a Robustness Index (Ri) that optimally combines IVIM-MRI parameters with enhanced stability for treatment response and hypoxia assessment.
Goal(s): To investigate the clinical utility of Ri (≈ 2f + Dt) in assessing ADT-induced changes and hypoxic environment in prostate cancer.
Approach: We compared Ri in ADT-treated and untreated prostate cancer tissues, evaluating its ability to detect treatment changes and correlate with hypoxia-related gene expression.
Results: Ri showed superior discriminative power (p=0.029) compared to conventional parameters (ADC: p=0.065; Dt: p=0.26), and IQR of Ri demonstrated significant correlation with hypoxia hallmark scores, indicating potential for both treatment monitoring and hypoxia assessment.
Impact: This optimized IVIM parameter Ri can be used for detection of ADT response and assessment of tumor hypoxic environment in prostate cancer prior to radiation therapy, providing a valuable tool for evaluating treatment effects on the tumor microenvironment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords